From: Challenges in exome analysis by LifeScope and its alternative computational pipelines
LifeScope | LifeScope-GATK | MAQ-GATK | BFAST-GATK | |
---|---|---|---|---|
Proband | ||||
ClinVar total | 1328 | 1261 | 1116 | 1150 |
Deleterious variants | 44;34pat + 10drug | 42;33pat + 9drug | 38;29pat + 9drug | 34;27pat + 7drug |
Deleterious at 15× | 32;23pat + 9drug | 38;28pat + 10drug | 24;19pat + 5drug | 21;15pat + 6drug |
Loss going to 15× | 27 % | 9.5 % | 37 % | 38 % |
COSMIC total | 468 | 366 | 310 | 299 |
COSMIC variants at 15× | 349 | 238 | 195 | 168 |
Loss going to 15× | 25 % | 35 % | 37 % | 44 % |
Mother | ||||
ClinVar total | 1288 | 1170 | 841 | 947 |
Deleterious variants | 47;38pat + 9drug | 41;33pat + 8drug | 38;30pat + 8drug | 36;30pat + 6drug |
Deleterious at 15× | 20;15pat + 5drug | 30;24pat + 6drug | 11;10pat + 1drug | 11; 8pat + 3drug |
Loss going to 15× | 57 % | 27 % | 71 % | 69 % |
COSMIC total | 395 | 292 | 197 | 194 |
COSMIC at 15× | 231 | 124 | 73 | 63 |
Loss going to 15× | 42 % | 52 % | 63 % | 68 % |
Father | ||||
ClinVar total | 1248 | 1126 | 950 | 959 |
Deleterious variants | 43;36pat + 7drug | 37;31pat + 6drug | 31;26pat + 5drug | 36;30pat + 6drug |
Deleterious at 15× | 19;16pat + 3drug | 26;22pat + 4drug | 12;11pat + 1drug | 11;9pat + 2drug |
Loss going to 15× | 56 % | 30 % | 61 % | 69 % |
COSMIC total | 444 | 340 | 270 | 197 |
COSMIC at 15× | 288 | 176 | 122 | 74 |
Loss going to 15× | 35 % | 37 % | 55 % | 62 % |